Finance

Lists
KZIA:NASDAQ
Kazia Therapeutics Ltd
9,47 USD
-1,30%
(-0,12) 1D
1-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KZIA...
Open
9,56 USD
High
9,68 USD
Low
9,37 USD
Mkt. cap
144,30 млн
Avg. vol.
340,83 миң
Volume
0,00
52-wk high
17,40 USD
52-wk low
4,86 USD
EPS
-6,31 USD
Beta
2,54
Shares outstanding
15,25 млн
No. of employees
6
Open
9,56 USD
High
9,68 USD
Low
9,37 USD
Mkt. cap
144,30 млн
Avg. vol.
340,83 миң
Volume
0,00
52-wk high
17,40 USD
52-wk low
4,86 USD
EPS
-6,31 USD
Beta
2,54
Shares outstanding
15,25 млн
No. of employees
6
News stories
From web sources and news partners
About Kazia Therapeutics Ltd
CEO-
Employees6
Founded1994
Headquarters-
Sector-
Websitekaziatherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to KZIA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for KZIA in the last 3 months.
Highest
Current 9,47 USD
40,00 USD (+322,39%)
Average
29,25 USD (+208,87%)
Lowest
18,00 USD (+90,07%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
18,00 USD
+90,1%
10/01/2026
Kambiz Yazdi
BTIG
Buy
Maintained
40,00 USD
+322,4%
09/22/2026
John Newman
Canaccord Genuity
Buy
Reiterated
29,00 USD
+206,2%
09/01/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
29,00 USD
+206,2%
08/13/2026
Naz Rahman
Maxim Group
Buy
Reiterated
30,00 USD
+216,8%
07/15/2026
Chad Messer
Lake Street
Buy
Initiated
32,00 USD
+237,9%
06/11/2026
Yale Jen
Laidlaw
Buy
Initiated
25,00 USD
+164%
04/15/2026
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
903,36 миң
903,36 миң
45,96 миң
45,96 миң
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,52 млн
1,52 млн
2,50 млн
2,50 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,81 млн
1,81 млн
4,28 млн
4,28 млн
Operating expense
3,33 млн
3,33 млн
6,78 млн
6,78 млн
Total operating expenses
3,33 млн
3,33 млн
6,78 млн
6,78 млн
Operating income
-2,42 млн
-2,42 млн
-6,73 млн
-6,73 млн
Other non operating income
-239,18 миң
-239,18 миң
372,46 миң
372,46 миң
EBT including unusual items
-5,93 млн
-5,93 млн
-6,28 млн
-6,28 млн
EBT excluding unusual items
-2,64 млн
-2,64 млн
-6,28 млн
-6,28 млн
Income tax expense
-805,23 миң
-805,23 миң
-
-
Effective tax rate
13,58%
13,58%
-
-
Other operating expenses
-
-
-
-
Net income
-5,12 млн
-5,12 млн
-6,28 млн
-6,28 млн
Net profit margin
-567,23%
-567,23%
-13 655,59%
-13 655,59%
Earnings per share
-
-
-
-
Interest and investment income
21,67 миң
21,67 миң
80,46 миң
80,46 миң
Interest expense
-
-
-
-
Net interest expenses
21,67 миң
21,67 миң
80,46 миң
80,46 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,11 млн
-2,19 млн
-6,50 млн
-6,50 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору